Effect of Ketogenic Diet on Quality of Life in Adults with Chronic Disease: A Systematic Review of Randomized Controlled Trials

Abstract

Background: Chronic diseases adversely affect quality of life (QOL). The ketogenic diet (KD) may improve the QOL. Objective: The aim of this systematic review was to summarize the available evidence of randomized controlled trials (RCTs) to establish the effect of KD on the QOL in adults with chronic diseases. Methods: Reporting followed PRISMA guidelines. We included randomized controlled trials (RCTs) conducted on adults with chronic disease including an intervention group that received KD and a control group, and where QOL was reported as outcome. We searched PubMed, APA PsycInfo, EMBASE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Cochrane Library, and Clinicaltrials.gov, and the references of the included articles and previous relevant reviews, without language or time restrictions. We critically appraised included studies and narratively synthesized their findings. Results: Nine RCTs were included. The risk of bias was low, except of allocation concealment and blinding. In patients with cancer: one RCT found an improvement in overall QOL, another reported improved physical component summary, and one found no superiority of KD in all QOL domains. In patients with neurological disorders: improved QOL was reported in Alzheimer’s disease patients, whereas no difference in mental and physical health QOL was noted in patients with multiple sclerosis. In patients with obesity and type II diabetes: one RCT reported superiority of energy-restricted KD in improving role functioning, mental health, health perceptions, and pain compared with guideline-based diet, whereas in another RCT, high and low carbohydrate diets achieved comparable improvements. Among patients with knee osteoarthritis, no differences between KD and low-fat groups were noted. Dietary compliance with the KD, reported in three studies, was shown to be high. Side effects were mostly noted during the first weeks of intervention, and adverse events were not markedly different with KD and the comparison diet. Conclusions: The evidence from RCTs investigating the effect of KD on QOL in adults with chronic disease is inconclusive. The promising effect noted in some included studies and the low rates of adverse events and side effects encourage future investigations in this regard.

The impact of ketogenic diet on some metabolic and non‐metabolic diseases: Evidence from human and animal model experiments

“…In a very recent study, obese and diabetic adults with chronic diseases experienced better sexual function. However, in another study, free serum testosterone increased, and attached testosterone to protein was increased (Abboud et al., 2021 ).…”

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

“…This can include vitamin D supplementation (357)(358)(359), probiotics (360), or Mediterranean diet (361). The evidence for the benefits of ketogenic diet and fasting in MS patients is still inconclusive (362), and ongoing studies will provide further evidence on their effects not only in MS symptomatology but also on disease progression (363).…”

Nutritional intervention for diabetes mellitus with Alzheimer's disease

“…Medium-chain triglyceride (MCT) oil, a major lipid component in KD, may promote ketogenesis and maintain mitochondrial function, in conjunctive therapy for AD patients ( 71 , 72 ). This dietary pattern could improve glycemic control in T2DM ( 73 ) and accompany cognitive impairment in AD ( 74 ). Long-term adherence to the KD is difficult with side effects attributable to the compromised dietary quality of micro-nutrient deficiency, along with poor appetite, nausea, constipation, fatigue, dyslipidemia, and unexpected weight loss ( 53 , 75 ).…”